Cystic Fibrosis Transmembrane Conductance Regulator Channel Dysfunction in Non-Cystic Fibrosis Bronchiectasis

被引:63
作者
Bienvenu, Thierry [2 ,4 ]
Sermet-Gaudelus, Isabelle [5 ,6 ]
Burgel, Pierre-Regis [3 ,6 ]
Hubert, Dominique [3 ]
Crestani, Bruno [7 ]
Bassinet, Laurence [8 ]
Dusser, Daniel [3 ,6 ]
Fajac, Isabelle [1 ,6 ]
机构
[1] Hop Cochin, Serv Explorat Fonctionnelles, AP HP, F-75014 Paris, France
[2] Hop Cochin, Lab Biochim & Genet Mol, AP HP, F-75014 Paris, France
[3] Hop Cochin, Serv Pneumol, AP HP, F-75014 Paris, France
[4] Univ Paris 05, INSERM, UMR8104, CNRS,U567, Paris, France
[5] Hop Necker Enfants Malad, AP HP, Serv Pediat Gen, Paris, France
[6] Univ Paris 05, Fac Med, Paris, France
[7] Hop Bichat Claude Bernard, AP HP, Serv Pneumol, F-75877 Paris, France
[8] Ctr Intercommunal Creteil, Serv Pneumol, Creteil, France
关键词
bronchiectasis; cystic fibrosis transmembrane conductance regulator; nasal potential difference; cystic fibrosis; NASAL POTENTIAL DIFFERENCE; CFTR GENE-MUTATIONS; ION-TRANSPORT; LUNG-FUNCTION; ADULTS; DISEASE; GUIDELINES; PHENOTYPE; DIAGNOSIS;
D O I
10.1164/rccm.200909-1434OC
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Rationale: Although in patients with diffuse bronchiectasis (DB) and a normal sweat test the presence of one mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene is frequently observed, its pathogenic role in the development of DB remains unclear. Objectives: To evaluate the association between CFTR heterozygosity and CFTR protein dysfunction in the airways of patients with DB. Methods: Nasal potential difference was measured in 122 patients with DB of unknown origin and with a normal sweat test (Cl- < 60 mmol/L). They were classified according to the presence of CFTR mutations: zero (85 patients), one (22 patients), or two mutations (15 patients). Control groups comprised 26 healthy subjects, 38 obligate heterozygotes for CFTR, and 92 patients with classic cystic fibrosis (CF) with an abnormal sweat test (Cl- >= 60 mmol/L). Patients classified as mild-CF were carrying at least one mild mutation and patients classified as severe-CF were homozygous for the F508del mutation. Measurements and Main Results: There was a continuum of airway CFTR dysfunction in the study population as shown by nasal potential difference measurements, ranging from normal values in healthy subjects, to intermediate values in subjects with DB, to highly abnormal values in subjects classified as severe-CF. This continuum of airway CFTR dysfunction was thus strongly associated with defects in the CFTR gene. Moreover, among patients with DB, a similar continuum in intermediate nasal potential difference was identified that was associated with the bearing of zero, one, or two CFTR mutations. These electrophysiological phenotypes and CFTR genotypes were also associated with the clinical phenotype, as shown by the frequency of Staphylococcus aureus and Pseudomonas aeruginosa bronchial colonization. Conclusions: Our study supports the hypothesis that a unique CFTR mutation may have pathogenic consequences in patients with DB.
引用
收藏
页码:1078 / 1084
页数:7
相关论文
共 37 条
[1]  
BIENVENU T, 2009, PEDIATR PULM, V32, P269
[2]   Complete mutational screening of the CFTR gene in 120 patients with pulmonary disease [J].
Bombieri, C ;
Benetazzo, M ;
Saccomani, A ;
Belpinati, F ;
Gilè, LS ;
Luisetti, M ;
Pignatti, PF .
HUMAN GENETICS, 1998, 103 (06) :718-722
[3]   Bronchiectasis in adult patients:: an expression of heterozygosity for CFTR gene mutations? [J].
Casals, T ;
De-Gracia, J ;
Gallego, M ;
Dorca, J ;
Rodríguez-Sanchón, B ;
Ramos, MD ;
Giménez, J ;
Cisteró-Bahima, A ;
Olveira, C ;
Estivill, X .
CLINICAL GENETICS, 2004, 65 (06) :490-495
[4]   Respiratory epithelial ion transport in patients with disseminated bronchiectasis [J].
Danner, I ;
Boisseau, P ;
Chailleux, E ;
Escande, D .
EUROPEAN RESPIRATORY JOURNAL, 1999, 13 (06) :1276-1280
[5]   Cystic fibrosis: terminology and diagnostic algorithms [J].
De Boeck, K. ;
Wilschanski, M. ;
Castellani, C. ;
Taylor, C. ;
Cuppens, H. ;
Dodge, J. ;
Sinaasappel, M. .
THORAX, 2006, 61 (07) :627-635
[6]   Best practice guidelines for molecular genetic diagnosis of cystic fibrosis and CFTR-related disorders - updated European recommendations [J].
Dequeker, Els ;
Stuhrmann, Manfred ;
Morris, Michael A. ;
Casals, Teresa ;
Castellani, Carlo ;
Claustres, Mireille ;
Cuppens, Harry ;
des Georges, Marie ;
Ferec, Claude ;
Macek, Milan ;
Pignatti, Pier-Franco ;
Scheffer, Hans ;
Schwartz, Marianne ;
Witt, Michal ;
Schwarz, Martin ;
Girodon, Emmanuelle .
EUROPEAN JOURNAL OF HUMAN GENETICS, 2009, 17 (01) :51-65
[7]  
Divac A, 2005, THORAX, V60, P85
[8]   ABNORMAL DISTRIBUTION OF CYSTIC-FIBROSIS DELTA-F508 ALLELE IN ADULTS WITH CHRONIC BRONCHIAL HYPERSECRETION [J].
DUMUR, V ;
LAFITTE, JJ ;
GERVAIS, R ;
DEBAECKER, D ;
KESTELOOT, M ;
LALAU, G ;
ROUSSEL, P .
LANCET, 1990, 335 (8701) :1340-1340
[9]   Nasal airway ion transport is linked to the cystic fibrosis phenotype in adult patients [J].
Fajac, I ;
Hubert, D ;
Guillemot, D ;
Honoré, I ;
Bienvenu, T ;
Volter, F ;
Dall'Ava-Santucci, J ;
Dusser, DJ .
THORAX, 2004, 59 (11) :971-976
[10]   Combination of ENaC and CFTR mutations may predispose to cystic fibrosis-like disease [J].
Fajac, I. ;
Viel, M. ;
Gaitchi, N. ;
Hubert, D. ;
Bienvenu, T. .
EUROPEAN RESPIRATORY JOURNAL, 2009, 34 (03) :772-773